📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression. (2021)

First Author: Conde J

Attributed to: ZMYND8-regulation of MITF as potential therapeutic target in melanoma funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acscentsci.1c00070

PubMed Identifier: 34079902

Publication URI: http://europepmc.org/abstract/MED/34079902

Type: Journal Article/Review

Volume: 7

Parent Publication: ACS central science

Issue: 5

ISSN: 2374-7943